Extremities Financial Regulatory SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution byBree MillerMarch 23, 2026
Extremities Regulatory Top Stories SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant byBree MillerMarch 19, 2026
Spine SINTX Technologies Signs Supply Agreement with EVONIK to Manufacture Silicon Nitride–PEEK Compound for AI-Assisted, 3D-Printed Patient-Specific Implants byTim AllenDecember 1, 2025
Biologics SINTX Technologies Expands Silicon Nitride Platform into Hybrid CFR-PEKK Trauma Plates byJosh SandbergAugust 4, 2025
Extremities Regulatory SINTX Technologies Submits FDA 510(k) for Silicon Nitride Foot & Ankle Medical Devices byBree MillerJuly 22, 2025
Biologics Recon Spine Top Stories SINTX Technologies Announces Strategic Vision Focused on Expansion Across Key Sectors byJosh SandbergJune 12, 2025
Recon Spine Top Stories SINTX Technologies Announces Strategic Changes to Board of Directors byTim AllenApril 3, 2025
Spine SINTX Technologies Announces Publication of Study Confirming Superior Performance of Silicon Nitride in Cervical Spine Fusion byTim AllenMarch 19, 2025
Financial Spine Top Stories SINTX Technologies Awarded Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants byJosh SandbergOctober 11, 2023
Financial SINTX Technologies Shares Select Preliminary Q4 2022 and Full Year 2022 Revenue Update byJosh SandbergJanuary 19, 2023
